Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion type Assertion NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_head.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion description "[In Kaplan-Meier analysis, the 5-year cancer-specific survival rate of the endometrioid adenocarcinoma patients with negative MMP-2 and positive TIMP-2 staining was 100%, whereas only 78% of patients presenting with positive MMP-2 and negative TIMP-2 staining results were alive at that time.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_provenance.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion evidence source_evidence_literature NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_provenance.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion SIO_000772 24344400 NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_provenance.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion wasDerivedFrom befree-20150227 NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_provenance.
- NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_assertion wasGeneratedBy ECO_0000203 NP561292.RAe6Qup0hNsucSh_w6SbwQAYFZ6AQ3zoyACpnCyoxbC9A130_provenance.